Francesco Maria Lavino has been appointed as Chief Executive Officer of F2G Ltd., a biopharmaceutical company, based in UK and Austria, and specialised in fungal infections.
ADVERTISEMENT
At the beginning of March, Dr Sophie Biguenet has been the new Chief Medical Officer of Paris-based Abivax SA.
Torben Osterlund is the new Chief Scientific Officer of the Dutch biotech company Toxys B.V., based in Leiden
Mads Krogsgaard Thomsen, CSO at Novo Nordisk, will take up the position as CEO of the Novo Nordisk Foundation effective from 1 March 2021.
Lund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018.
Märta Segerdahl will take over the position as Chief Medical Officer of Swedish AlzeCure Pharma AB on April.
Spanish Accure Therapeutics appoints Dr Rossella Medori as new Chief Medical officer.
Muttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer,
Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer.
Bart Wuurman joined the young Belgian biotechnology company Apaxen S.A. in November as new CEO.